National survey of more than 1,100 bladder cancer patients finds nearly 80% report fear of recurrence, rising above 90% among patients under ...

Please provide your email address to receive an email when new articles are posted on . Women with higher BMI, greater anatomical failure and smoking had a greater recurrence of pelvic organ prolapse ...

New research from Memorial Sloan Kettering Cancer Center (MSK) medical oncologist Dean Bajorin, MD, and colleagues found that patients who received nivolumab (Opdivo®) after bladder cancer surgery ...

Immunotherapy after surgery helped reduce cancer recurrence in patients with urothelial cancer of the bladder or other sites in the urinary tract that had invaded the muscle and therefore posed a high ...

Dr. Matthew Galsky spoke with CURE about the KEYNOTE-B15 trial results and their potential impact on muscle-invasive bladder cancer care. At the 2026 ASCO Genitourinary Cancers Symposium, the ...

The risk of requiring surgery for pelvic-organ prolapse or urinary incontinence increases with age, and reoperations are not uncommon. Many different graft materials have been used to help reduce ...

Flushing the bladder with a common chemotherapy drug immediately after surgery significantly reduces the chances of bladder cancer returning, according to a major study by SWOG, an international ...

DEAR MAYO CLINIC: I just had a total hysterectomy due to an abnormal Pap smear. At that time, my bladder was also corrected, since it had been descended for many years. What kind of care is most ...

MSK medical oncologist Dean Bajorin says the immunotherapy drug nivolumab proved effective at preventing bladder cancer from returning after surgery. Photo from 2018. Update: On August 19, 2021, the ...